Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5864 Articles

Jon C. Ogg | Feb 22, 2014 at 9:06 AM EST

Four Biotech Stocks Called to Double

ThinkstockThe biotech market has been on fire this year, and there is every indication that things will continue. With huge…

cgblaine22 | Feb 21, 2014 at 12:35 PM EST

Assisted Living Merger May Set Off More Deals

Shares of Emeritus and Brookdale Senior Living were rising nicely Friday as investors cheered the merger of the big assisted-living…

Jon C. Ogg | Feb 19, 2014 at 10:45 AM EST

Chelsea Moving on to the Revenue Stage of Its Cycle

Chelsea Therapeutics is finding a serious victory from its hypotension drug. Shares hit a multiyear high after it confirmed an…

Trey Thoelcke | Feb 17, 2014 at 9:40 AM EST

Biogen Idec Chairman: New Boss Same as the Old Boss?

Biogen Idec has announced that Chairman William D. Young will retire from the its board of directors and will be…

Trey Thoelcke | Feb 17, 2014 at 7:05 AM EST

Biotech Buyout Bolsters Novartis Cancer Portfolio

Novartis announced Monday morning that it will acquire privately held startup biotech CoStim Pharmaceuticals. Terms of the deal were not…

Jon C. Ogg | Feb 13, 2014 at 10:40 AM EST

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

With top biotechnology and health care companies from around the world attending the Leerink Global Healthcare, it is a good…

Trey Thoelcke | Feb 12, 2014 at 6:50 AM EST

Short Sellers Shy Away From Biotechs

24/7 Wall St. has tracked the short interest in leading biotech and emerging pharmaceutical stocks. By and large, short sellers…

Jon C. Ogg | Feb 11, 2014 at 3:03 PM EST

Health Insurance Giants Off to Rocky 2014: Obamacare vs. Affordable Care

ThinkstockHealth insurance providers are not having a good start to 2014. The Affordable Care Act, or Obamacare, is not bringing…

cgblaine22 | Feb 11, 2014 at 11:15 AM EST

Mallinckrodt May Have to Pay More for Cadence

Cadence Pharmaceuticals agreed Tuesday to be bought out by Mallinckrodt for $1.3 billion, or a more than 27% premium to…

Jon C. Ogg | Feb 10, 2014 at 3:20 PM EST

Gilead Going to $90, or $110

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) is rising on Monday after two analysts made positive calls on the biotech giant. As…

Jon C. Ogg | Feb 7, 2014 at 8:15 AM EST

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Here are the top biotech stocks to buy that are trading near the $5 dollar level. We have updated coverage…

Trey Thoelcke | Feb 6, 2014 at 9:30 AM EST

Five Stocks That May Get a Huge Lift From the Affordable Care Act

In a new research report, J.P. Morgan analysts completed some exhaustive work and have narrowed down the list of stocks…

Jon C. Ogg | Feb 6, 2014 at 7:30 AM EST

Teva Delivers on Earnings in Turnaround

Teva Pharmaceutical Industries is out with its fourth-quarter earnings report, and it looks as though the bad trends may be…

Paul Ausick | Feb 5, 2014 at 8:20 AM EST

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to…

Jon C. Ogg | Feb 4, 2014 at 4:29 PM EST

Despite Size, Gilead Keeps Growing and Growing

ThinkstockGilead Sciences Inc. (NASDAQ: GILD) is the biggest biotech company in America, and it is one of the top performers…

1 … 293 294 295 296 297 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Four Biotech Stocks Called to Double

Assisted Living Merger May Set Off More Deals

Chelsea Moving on to the Revenue Stage of Its Cycle

Biogen Idec Chairman: New Boss Same as the Old Boss?

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Short Sellers Shy Away From Biotechs

Health Insurance Giants Off to Rocky 2014: Obamacare vs. Affordable Care

Mallinckrodt May Have to Pay More for Cadence

Gilead Going to $90, or $110

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Five Stocks That May Get a Huge Lift From the Affordable Care Act

Teva Delivers on Earnings in Turnaround

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Despite Size, Gilead Keeps Growing and Growing

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

Health and Healthcare Articles

All Health and Healthcare Articles

Four Biotech Stocks Called to Double

Assisted Living Merger May Set Off More Deals

Chelsea Moving on to the Revenue Stage of Its Cycle

Biogen Idec Chairman: New Boss Same as the Old Boss?

Biotech Buyout Bolsters Novartis Cancer Portfolio

Top Pharma and Biotech Stocks to Buy From Key Investor Conference

Short Sellers Shy Away From Biotechs

Health Insurance Giants Off to Rocky 2014: Obamacare vs. Affordable Care

Mallinckrodt May Have to Pay More for Cadence

Gilead Going to $90, or $110

Eight Biotech Stocks Trading Near $5 With Huge Upside Potential

Five Stocks That May Get a Huge Lift From the Affordable Care Act

Teva Delivers on Earnings in Turnaround

Merck Earnings Fail to Dazzle, but the Company’s Story Remains Strong

Despite Size, Gilead Keeps Growing and Growing

This High-Yield Bond ETF Offers Steady Cash Flow and Low Volatility

This Natural Resources ETF Has Silently Outperformed The S&P 500 Year-To-Date While Yielding 5%

XRP vs Solana vs Ethereum: Which Altcoin is the Best Buy for Upside Right Now?

Featured Reads

39% of Americans Are Betting on Crypto and Prediction Markets Instead of Saving

A $300,000 Annuity Guarantees $1,900 a Month for Life, but Here Is What Retirees Are Giving Up